Daniel P. O'Day has served as Chairman and Chief Executive Officer of Gilead Sciences since 2019. Before joining Gilead he spent a more than 30-year career at Roche, most recently as Chief Executive Officer of Roche Pharmaceuticals and a member of Roche's Corporate Executive Committee, holding executive positions across the pharmaceutical and diagnostics divisions in North America, Europe and Asia.